Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts

Diabetologia

Volumn 41, Issue 3, 1998, Pages 315-321

  Takeda, Y ^a   Gotoh, M ^a   Dono, K ^a   Nishihara, M ^a   Grochowiecki, T ^a   Kimura, F ^a   Yoshida, T ^a   Ohta, Y ^a   Ota, H ^a   Ohzato, H ^a   Umeshita, K ^a   Takeda, T ^a   Matsuura, N ^a   Sakon, M ^a   Kayagaki, N ^b   Yagita, H ^b   Okumura, K ^b   Miyasaka, M ^a   Monden, M ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Composite graft; Fas; Fas ligand; Islet transplantation; Testicular tissue

Indexed keywords

FAS LIGAND;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; FAS LIGAND PROTEIN; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; TESTIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 15644363704     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050909     Document Type: Article

References (27)

1. Trauth BC, Klas C, Peters AM et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 21: 301-305
2. Yonehara S, Ishii A, Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756
3. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140: 197-205
4. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
5. Lynch DH, Watson ML, Alderson MR et al. (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136
6. Takahashi T, Tanaka M, Brannan CI et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976
7. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
8. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192
9. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr (1996) Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273: 109-112
10. Allison J, Georgiou MH, Strasser A, Vaux LD (1997) Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 94: 3943-3947
11. Kang MS , Schneider BD, Lin Z et al. (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med 7: 738-743
12. Kayagaki N, Yamaguchi N, Nagao F et al. (1997) Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci USA 94: 3914-3919
13. Tamatani T, Miyasaka M (1990) Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 2: 165-171
14. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP (1985) An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438
15. Fawcett DW (1986) Male reproductive system. In: Fawcett DW (ed) Bloom and Fawcett a textbook of histology. Saunders, Philadelphia, pp 798-802
16. Korbutt SG, Elliott FJ, Rajotte VR (1997) Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46: 317-322
17. Seino K, Kayagaki N, Okumura Ko, Yagita H (1997) Antitumor effect of locally produced CD95 ligand. Nature Med 3: 165-170
18. Yagita H, Seino K, Kayagaki N, Okumura K (1996) CD95 ligand in graft rejection. Nature 379: 682
19. Baggiolini M, Clark-Lewis I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307: 97-101
20. Cacalano G, Lee J, Kikly K et al. (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265: 682-684
21. Abreu-Martin MT, Virdrich A, Lynch DH, Targan SR (1995) Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 155: 4147-4154
22. Sekine C, Yagita H, Kobata T, Hasumura T, Nishioka K, Okumura K (1996) Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of Cpp32-mediated apoptosis. Biochem Biophys Res Commun 228: 14-20
23. Tanaka M, Suda T, Takahashi T, Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14: 1129-1135
24. Mariani S M, Matiba B, Baumler C Krammer P H (1995) Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25: 2303-2307
25. Kayagaki N, Kawasaki A, Ebata T et al. (1995) Metalloprotease-mediated release of human Fas ligand. J Exp Med 182: 1777-1783
26. Yamada K, Takane-Gyotoku N, Yuan X et al. (1996) Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39: 1306-1312
27. Chervonsky VA, Wang Y, Wong SF et al. (1997) The role of Fas in autoimmune diabetes. Cell 89: 17-24